Reports: Purdue weighs Chapter 11
The drugmaker is facing thousands of lawsuits saying the company contributed to the opioid crisis.
Lawsuit
Judge denies McCann, Interpublic motion to dismiss Perrott lawsuit
IPG and McCann filed motions to dismiss and transfer the lawsuit last month.
Bayer dropped pitchwoman for bobblehead to save money: lawsuit
The lawyer for former spokesperson Phoebe Jonas said Bayer created “a big headache for everyone.”
Five things for pharma marketers to know: Monday, January 22, 2018
Sanofi to buy Bioverativ for $11.6 billion; Celgene to acquire Juno for $9 billion; Teva to lay off more than 200 in Philadelphia
Five things for pharma marketers to know: Thursday, January 18, 2018
Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution
Five things for pharma marketers to know: Wednesday, January 10, 2018
Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict
Five things for pharma marketers to know: Tuesday, January 9, 2018
Shire considers splitting into two units; New Jersey finalizes physician-pharma gift limit; more biotech M&As expected in 2018
Five things for pharma marketers to know: Monday, December 18, 2017
CVS/Aetna deal will affect healthcare benefits; lawmakers pressure DEA to curb painkiller supply; Allergan and Richter’s Vraylar sees positive results for bipolar depression
Five things for pharma marketers to know: Tuesday, December 12, 2017
FDA issues prescription drug promotion guidance; FDA approves first follow-on biologic of Lilly’s Humalog; drugmakers allegedly hired nurses to promote drugs
Five things for pharma marketers to know: Wednesday, December 6, 2017
FDA approves Novo’s diabetes drug; Walgreens undergoes rebranding in the wake of CVS-Aetna merger; pharma increasingly transparent about clinical trial data
